Published in Gene Therapy Weekly, January 26th, 2006
"ASF/SF2 is an SR protein splicing factor that participates in constitutive and alternative pre-mRNA splicing and is essential for cell viability," wrote X.L. Li and colleagues, Columbia University.
"However, although several hallmarks of apoptosis are apparent, internucleosomal DNA...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.